| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics, Inc. | 10%+ Owner | Common Stock | 1,324,446 | $23,601,627 | $17.82 | 12 Jan 2026 | Indirect |
| Atara Biotherapeutics, Inc. | 10%+ Owner | Warrants | 259,163 | $1,713,041 | $6.61 | 28 Nov 2025 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | 12 Jan 2026 | 1 | -$489,019 | 4 | 10%+ Owner | 14 Jan 2026, 21:16 |
| ATRA | Atara Biotherapeutics, Inc. | 28 Nov 2025 | 3 | -$322,156 | 4 | 10%+ Owner | 01 Dec 2025, 17:00 |
| ATRA | Atara Biotherapeutics, Inc. | 15 Aug 2025 | 1 | +$670,422 | 4 | 10%+ Owner | 19 Aug 2025, 20:15 |
| ATRA | Atara Biotherapeutics, Inc. | 17 Jul 2025 | 1 | +$186,372 | 4 | 10%+ Owner | 21 Jul 2025, 09:00 |
| ATRA | Atara Biotherapeutics, Inc. | 16 May 2025 | 0 | $0 | 3 | 10%+ Owner | 21 May 2025, 18:00 |